Clinical Trial: A Clinical Study of REGEND001 for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)

U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07828353) titled 'A Clinical Study of REGEND001 for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)' on Sept. 14.

Brief Summary: Chronic obstructive pulmonary disease (COPD) is a common, progressive, and heterogeneous respiratory disorder. It is associated with substantial morbidity and mortality worldwide, leading to progressive decline in lung function, impaired quality of life, and a significant healthcare burden. REGEND001, made from airway basal stem cells with ability to regenerate lung tissue, is promising to COPD treatment. In this study, a multicenter, randomized, blinded, placebo-parallel-controlled trial is performed to veri...